首页> 美国卫生研究院文献>Molecules >Novel Biodegradable Polyesters. Synthesis and Application as Drug Carriers for the Preparation of Raloxifene HCl Loaded Nanoparticles
【2h】

Novel Biodegradable Polyesters. Synthesis and Application as Drug Carriers for the Preparation of Raloxifene HCl Loaded Nanoparticles

机译:新型生物可降解聚酯。载有盐酸雷洛昔芬的纳米粒子的合成及其作为药物载体的应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Raloxifene HCl is a drug with poor bioavailability and poor water solubility. Furthermore nο pharmaceutically acceptable organic solvent has been reported before to dilute the drug. It was observed that Raloxifene HCl can be diluted in a solvent mixture of acetone/water or ethanol/water. The aim of this study was to use biodegradable polymers in order to prepare Raloxifene HCl nanoparticles. For this purpose a series of novel biodegradable poly(ethylene succinate-co-propylene adipate) P(ESu-co-PAd) polyesters were synthesized following the polycondensation method and further, poly(ethylene succinate) (PESu) and poly(propylene adipate) (PPAd) were used. The prepared polyesters were characterized by intrinsic viscosity measurements, end group analysis, enzymatic hydrolysis, Nuclear Magnetic Resonance Spectroscopy (1Η-NMR and 13C-NMR) and Wide-angle X-ray Diffractometry (WAXD). The drug nanoparticles have been prepared by a variation of the co-precipitation method and were studied by Wide-angle X-ray Diffractometry (WAXD), FTIR spectrometry, light scattering size distribution, Scanning Electron Microscopy (SEM) and release behavior measurements. The interactions between the polymers and the drug seem to be limited, so the drug occurs in crystalline form in all nanoparticles. The size of the nanoparticles seems to be in the range of 150-350 nm, depending on the polymer that was used. The drug release depends on the melting point and degree of crystallinity of the polyesters used. An initial high release rate was recorded followed by very slow rates of controlled release.
机译:盐酸雷洛昔芬是一种生物利用度和水溶性差的药物。此外,在稀释药物之前还没有可药用的有机溶剂的报道。观察到盐酸雷洛昔芬可以在丙酮/水或乙醇/水的溶剂混合物中稀释。这项研究的目的是使用可生物降解的聚合物来制备盐酸雷洛昔芬纳米颗粒。为此目的,通过缩聚方法合成了一系列新型的可生物降解的聚(琥珀酸乙烯-己二酸共聚丙二酯)P(ESu-co-PAd)聚酯,此外,还合成了聚琥珀酸乙烯酯(PESu)和聚己二酸丙二酯。 (PPAd)。通过特性粘度测量,端基分析,酶水解,核磁共振波谱( 1 H -NMR和 13 C -NMR)和广角X射线衍射(WAXD)。通过改变共沉淀方法制备了药物纳米颗粒,并通过广角X射线衍射(WAXD),FTIR光谱,光散射尺寸分布,扫描电子显微镜(SEM)和释放行为测量对其进行了研究。聚合物与药物之间的相互作用似乎受到限制,因此药物以结晶形式出现在所有纳米颗粒中。取决于所使用的聚合物,纳米颗粒的尺寸似乎在150-350nm的范围内。药物释放取决于所用聚酯的熔点和结晶度。记录到最初的高释放速率,然后是非常缓慢的控释速率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号